AstraZeneca To Add Defendant In Nexium Patent Suit

Law360, New York (December 17, 2008, 12:00 AM EST) -- AstraZeneca Corp. has won a bid to add a defendant, Cipla Ltd., and a patent to its infringement suit against Teva Pharmaceutical Industries Inc. and its Ivax Corp. subsidiary over patents for heartburn medication Nexium, despite a flood of objections from Teva.

U.S. District Judge Tonianne J. Bongiovanni of the U.S. District Court for the District of New Jersey signed an order Monday granting AstraZeneca's request to amend its complaint.

AstraZeneca sought to add Mumbai, India-based Cipla to the lawsuit after learning from Teva's abbreviated new...
To view the full article, register now.